Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Article in Pharmaceutical Research (May 2020)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Optimal tolerability and high efficacy of a modified schedule of lapatinib–capecitabine in advanced breast cancer patients
Article in Journal of Cancer Research and Clinical Oncology (November 2013)
Chronotherapy and the molecular clock: Clinical implications in oncology
Article in Advanced Drug Delivery Reviews (June 2010)